Yu-Ting Peng

Cdk5 Directly Targets Nuclear p21CIP1 and Promotes Cancer Cell Growth.

J. Hsieh, Chih-Ho Lai, Chih-Hsiang Chang, 2016, Cancer research.

Relationship of interleukin‐8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development

Shun-Fa Yang, M. Chien, Lin-Hung Wei, 2011, Journal of surgical oncology.

Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser727 on STAT3 in prostate cancer cells

J. Hsieh, F. Hsu, E. Lin, 2013 .

Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.

J. Hsieh, F. Hsu, E. Lin, 2013, American journal of physiology. Endocrinology and metabolism.

Cyclin-dependent kinase 5 modulates STAT 3 and androgen receptor activation through phosphorylation of Ser 727 on STAT 3 in prostate cancer cells

J. Hsieh, F. Hsu, E. Lin, 2013 .

Clinical Aggressiveness of Myxofibrosarcomas Associates with Down-Regulation of p12CDK2AP1: Prognostic Implication of a Putative Tumor Suppressor that Induces Cell Cycle Arrest and Apoptosis Via Mitochondrial Pathway

Wen-Ren Wu, Chien-Feng Li, Y. Shiue, 2014, Annals of Surgical Oncology.

miR-197-3p reduces epithelial–mesenchymal transition by targeting ABCA7 in ovarian cancer cells

L. Qin, Cheng Shui, Weiquan Xie, 2020, 3 Biotech.

Upregulation of cyclin-dependent kinase inhibitors CDKN1B and CDKN1C in hepatocellular carcinoma-derived cells via goniothalamin-mediated protein stabilization and epigenetic modifications

F. Chang, Wen-Ren Wu, Y. Shiue, 2015, Toxicology reports.